“…For the determination of iron (II) and ascorbic acid in pharmaceuticals the flow injection (Alonso, Bartrolí, del Valle, & Barber, 1989;Alonso, Bartroli, Delvalle, Escalada, & Barber, 1987;Alonso-Chamarro, Bartroli, & Barber, 1992;Araujo, Lima, Alonso-Chamarro, Bartroli, & Poch, 1991;Cerda & Cerda, 2009;Falkova, Pushina, Bulatov, Alekseeva, & Moskvin, 2014;Horstkotte & Cerdà, 2009;ISO 5725-1, 1994; IUPAC, 1997; Kukoc-Modun, Biocic, & Radic, 2012;Lenghor et al, 2002;Mervartova et al, 2007;Molina-Diaz, Ortega-Carmona, & Pascual-Reguera, 1998;Mortatti, Krug, Pessenda, & Zagatto, 1982;Ruzicka & Hansen, 1975;Ruzicka & Marshall, 1990;Tzanavaras & Themelis, 2007;Udnana et al, 2004) and sequential injection (Lenghor et al, 2002;Oliveira & Masini, 2001;Tesfaldet, van Staden, & Stefan, 2004) techniques were developed, which provide high sensitivity (Table 1) ). However, they are focused only on the determination of iron (II) or ascorbic acid.…”